Berberine No Help for Metabolic Markers in Patients With Obesity and MASLD

By News Health
38 minutes Ago

(MedPage Today) — Treatment with the supplement berberine failed to reduce visceral adipose tissue or liver fat in adults with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized trial from China found….

Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/119460

Author :

Publish date : 2026-01-16 16:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Darlington hospital violated trans complaint nurses' dignity, tribunal rules

RFK Jr. Targets Cellphone Radiation; Ex-CEO of COVID Shot Maker Sued; Flu Vax Data

Stiffer Colon Could Signal Early-Onset CRC Risk

Cancelling plans may be more socially acceptable than you think

Harm Reduction Programs Seek New Funding Sources

Lacking willpower this January? Here's how to reframe your mind